Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1961 1
1962 1
1969 1
1975 1
1976 1
1979 2
1980 1
1981 1
1983 1
1984 3
1985 4
1986 1
1987 1
1988 7
1989 6
1990 2
1991 5
1992 3
1993 3
1994 3
1995 8
1996 3
1998 9
2000 8
2001 1
2002 7
2003 3
2004 10
2005 4
2006 15
2007 21
2008 14
2009 32
2010 28
2011 28
2012 43
2013 56
2014 40
2015 47
2016 53
2017 57
2018 71
2019 69
2020 91
2021 150
2022 150
2023 215
2024 256
2025 292
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,641 results

Results by year

Filters applied: . Clear all
Page 1
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.
Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young KC, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu S, Goldberg SA, Lee SA, Lynch KL, Kelly JD, Martin JN, Münch J, Deeks SG, Henrich TJ, Roan NR. Yin K, et al. Among authors: ibrahim r. Nat Immunol. 2024 Feb;25(2):218-225. doi: 10.1038/s41590-023-01724-6. Epub 2024 Jan 11. Nat Immunol. 2024. PMID: 38212464 Free PMC article.
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.
Tsimberidou AM, Alayli FA, Okrah K, Drakaki A, Khalil DN, Kummar S, Khan SA, Hodi FS, Oh DY, Cabanski CR, Gautam S, Meier SL, Amouzgar M, Pfeiffer SM, Kageyama R, Yang E, Spasic M, Tetzlaff MT, Foo WC, Hollmann TJ, Li Y, Adamow M, Wong P, Moore JS, Velichko S, Chen RO, Kumar D, Bucktrout S, Ibrahim R, Dugan U, Salvador L, Hubbard-Lucey VM, O'Donnell-Tormey J, Santulli-Marotto S, Butterfield LH, Da Silva DM, Fairchild J, LaVallee TM, Padrón LJ, Sharma P. Tsimberidou AM, et al. Among authors: ibrahim r. J Exp Med. 2024 Oct 7;221(10):e20240152. doi: 10.1084/jem.20240152. Epub 2024 Aug 27. J Exp Med. 2024. PMID: 39190534 Free PMC article.
IL-7-dependent and -independent lineages of IL-7R-dependent human T cells.
Arango-Franco CA, Ogishi M, Unger S, Delmonte OM, Orrego JC, Yatim A, Velasquez-Lopera MM, Zea-Vera AF, Bohlen J, Chbihi M, Fayand A, Sánchez JP, Rojas J, Seeleuthner Y, Le Voyer T, Philippot Q, Payne KJ, Gervais A, Erazo-Borrás LV, Correa-Londoño LA, Cederholm A, Gallón-Duque A, Goncalves P, Doisne JM, Horev L, Charmeteau-de Muylder B, Álvarez JÁ, Arboleda DM, Pérez-Zapata L, Vásquez-Echeverri E, Moncada-Vélez M, López JA, Caicedo Y, Palterer B, Patiño PJ, Montoya CJ, Chaldebas M, Zhang P, Nguyen T, Ma CS, Jeljeli M, Alzate JF, Cabarcas F, Khan T, Rinchai D, Prétet JL, Boisson B; Generalized Verrucosis Japanese Consortium; Marr N, Ibrahim R, Molho-Pessach V, Boisson-Dupuis S, Kiritsi D, Barata JT, Landegren N, Neven B, Abel L, Lisco A, Béziat V, Jouanguy E, Bustamante J, Di Santo JP, Tangye SG, Notarangelo LD, Cheynier R, Natsuga K, Arias AA, Franco JL, Warnatz K, Casanova JL, Puel A. Arango-Franco CA, et al. Among authors: ibrahim r. J Clin Invest. 2024 Oct 1;134(19):e180251. doi: 10.1172/JCI180251. J Clin Invest. 2024. PMID: 39352394 Free PMC article.
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma.
Khoury R, Khalife N, Ibrahim R, Saleh K. Khoury R, et al. Among authors: ibrahim r. Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):923-926. doi: 10.21037/hbsn-23-476. Epub 2023 Nov 15. Hepatobiliary Surg Nutr. 2023. PMID: 38115933 Free PMC article. No abstract available.
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma.
Rahmqvist I, Engström E, Mellström E, Ibrahim RR, Pujol-Calderón F, Dahlstrand Rudin A, Ordqvist Redfors A, Rostamzadeh N, Di Rienzo R, Franssila W, Khashan R, Xylander M, Karlsson C, Ek T, Andersson D, Österlund T, Gaarder J, Fagman H, Fransson S, Martinsson T, Ståhlberg A, Dalin M. Rahmqvist I, et al. Among authors: ibrahim rr. Biomark Res. 2024 Nov 26;12(1):148. doi: 10.1186/s40364-024-00688-5. Biomark Res. 2024. PMID: 39593169 Free PMC article.
Computed Tomography and Coronary Plaque Analysis.
Alhammouri H, Ibrahim R, Alasmar R, Abdelnabi M, Habib E, Allam M, Pham HN, Elbenawi H, Farina J, Tamarappoo B, Jokerst C, Lee K, Ayoub C, Arsanjani R. Alhammouri H, et al. Among authors: ibrahim r. Tomography. 2025 Jul 30;11(8):85. doi: 10.3390/tomography11080085. Tomography. 2025. PMID: 40863876 Free PMC article. Review.
Targeting RET mutation in medullary thyroid cancer.
Assi T, Tikriti Z, Shayya A, Ibrahim R. Assi T, et al. Among authors: ibrahim r. Pharmacogenomics. 2024 Feb;25(3):113-115. doi: 10.2217/pgs-2023-0234. Epub 2024 Mar 7. Pharmacogenomics. 2024. PMID: 38450459 No abstract available.
1,641 results